New Tryptophan-Based Antioxidant Molecules Outperform Vitamin E Standard in Lab Tests

Chemists have designed and synthesized a family of twenty novel antioxidant compounds, and one of them has done something remarkable in laboratory tests: it neutralized harmful free radicals more effectively than Trolox, the vitamin E analog that serves as the gold-standard benchmark in antioxidant research. The lead molecule, known as TrpOH-3, achieved a half-maximal inhibitory concentration of just 3.96 micromolar in the ABTS radical-scavenging assay and 9.17 micromolar in the DPPH assay, comfortably beating Trolox in both. The work, published in the journal Pharmacia, combines traditional synthetic chemistry with computational modeling to point the way toward new treatments for diseases driven by oxidative stress.

The rationale behind the study lies in a fundamental biological balancing act. Cells constantly produce reactive oxygen species, or ROS, as byproducts of normal metabolism, particularly in the mitochondria where electron leakage from the respiratory chain generates superoxide radicals. When antioxidant defenses fail to keep pace, these reactive species accumulate and attack lipids, proteins, and DNA, a state known as oxidative stress. Chronic oxidative stress has been implicated in an astonishingly broad range of conditions, from Alzheimer’s and Parkinson’s disease to cancer, depression, obesity, and cataracts, which is why chemists around the world are racing to develop more powerful and selective antioxidant molecules.

The research team focused on a class of compounds called hydrazide-hydrazones, which are built around an azomethine linkage formed by condensing aldehydes with primary amines. Schiff bases of this kind are prized in medicinal chemistry because the imine bond promotes extended pi-conjugation and electron delocalization, allowing radicals to be stabilized and quenched efficiently. When phenolic hydroxyl groups sit close to this linkage, they enable hydrogen atom transfer and single electron transfer mechanisms, the two dominant pathways by which small molecules neutralize free radicals. These scaffolds can also chelate pro-oxidant transition metals such as iron and copper, blocking the Fenton reactions that generate the notoriously destructive hydroxyl radical.

What makes the new study distinctive is its modular design. The researchers attached hydroxyl-substituted aromatic aldehydes to a pyrrole core bearing five different amino acid scaffolds: glycine, beta-alanine, isoleucine, phenylalanine, and tryptophan. Each amino acid was chosen for a specific purpose. Glycine and beta-alanine add flexible polar groups that improve water solubility, isoleucine contributes hydrophobic branching that may help the molecules cross cell membranes, phenylalanine enables pi-stacking interactions with radical species, and tryptophan brings an indole ring that is itself a formidable peroxyl radical scavenger. The pyrrole ring serves as the main radical-trapping unit, while the hydrazone nitrogen-hydrogen group loses a proton to form a stable, resonance-delocalized radical across the molecule.

The synthesis itself was strikingly efficient. By refluxing equimolar amino acid hydrazides with the aldehyde derivatives in glacial acetic acid for just one hour, the team obtained all twenty target compounds as crystalline solids in yields ranging from 83 to 95 percent. Every compound was rigorously characterized by infrared spectroscopy and both proton and carbon-13 nuclear magnetic resonance, with diagnostic signals confirming the imine linkage, the phenolic hydroxyl groups, and the intact pyrrole core. Sharp melting points between 168 and 251 degrees Celsius indicated pure, stable crystalline forms suitable for biological testing.

Antioxidant performance was assessed using two complementary assays. The DPPH test measures the ability of a compound to donate a proton to a stable violet-colored free radical, while the ABTS test probes electron transfer by monitoring the decolorization of a blue-green radical cation. The results revealed a clear structure-activity relationship. Tryptophan-derived compounds dominated the rankings, with beta-alanine derivatives close behind, while glycine analogs lacking a side chain performed worst, with inhibitory concentrations often exceeding 200 micromolar. The aldehyde component mattered just as much: derivatives bearing catechol-like arrangements of adjacent hydroxyl groups, specifically the 2,3,4- and 2,4,5-trihydroxy patterns, dramatically outperformed compounds whose hydroxyl groups were arranged differently, because adjacent hydroxyls facilitate resonance stabilization of the resulting phenoxyl radical and more efficient hydrogen atom donation.

TrpOH-3, which pairs the tryptophan scaffold with a 2,4,5-trihydroxybenzaldehyde fragment, emerged as the undisputed champion of the series. Three other compounds, TrpOH-4, BAlaOH-3, and PheOH-2, also matched or beat Trolox in both assays, confirming that the design principles were sound rather than a lucky outlier. The indole ring of tryptophan appears to be the key differentiator, providing an additional electron-rich system that stabilizes radical intermediates and supports both proton and electron transfer simultaneously.

To explore whether the lead compound could do more than simply mop up radicals, the team turned to molecular docking against the Keap1 Kelch domain, a protein that acts as a cellular brake on the Nrf2 pathway, the master regulator of the body’s own antioxidant defenses. Disrupting the Keap1-Nrf2 interaction releases Nrf2 to activate genes for protective enzymes such as those that produce glutathione. TrpOH-3 docked into the Keap1 binding pocket with a competitive score of minus 6.25 kilocalories per mole, forming direct hydrogen bonds with Ser602 and Tyr525, a water-mediated bond with Ser363, and an unusual directional halogen bond between its bromine substituent and Tyr334. This multifaceted interaction profile suggests the molecule mimics key contacts at the natural Keap1-Nrf2 interface, positioning it as a promising non-covalent inhibitor scaffold.

Computational pharmacokinetic predictions using the QikProp module painted a nuanced picture of the lead compound’s drug-likeness. TrpOH-3 violates Lipinski’s rule of five in only one parameter, molecular weight, which at 645.5 daltons exceeds the conventional 500-dalton threshold. That heft, combined with three free polar hydroxyl groups, limits passage through biological membranes, yielding a predicted human oral absorption of just 56 percent and poor penetration of the blood-brain barrier, a potential drawback for central nervous system applications. The octanol-water partition coefficient of 4.65 and other descriptors fall within acceptable pharmaceutical ranges, so the main optimization challenge is clear: trim the molecular weight without sacrificing the radical-scavenging machinery.

The study demonstrates how modern drug discovery can weave together synthesis, biological assays, structure-activity analysis, docking, and ADME prediction into a single rational workflow. By identifying tryptophan scaffolds and catechol-type hydroxyl patterns as the winning combination, and by validating a plausible mechanism of action at the Keap1-Nrf2 interface, the researchers have delivered a versatile lead compound for developing next-generation antioxidants aimed at neurodegeneration and inflammation. The team’s next steps include preparing structural analogs with improved permeability, running enzyme inhibition assays, and validating the most promising candidates in living systems, a pipeline that could eventually translate these laboratory champions into real therapies for oxidative stress-related disorders.

Subject of Research: Design and antioxidant evaluation of novel pyrrole-based hydrazide-hydrazone compounds

Article Title: Design, synthesis, antioxidant activity, SAR, molecular docking, and ADME studies of novel hydroxyl-derived compounds

Article References: Mateev, E., Tzankova, D., Karatchobanov, V., Irfan, A., Pepeldzhiyska, E.-M., Kostov, S., & Zlatkov, A. (2026). Design, synthesis, antioxidant activity, SAR, molecular docking, and ADME studies of novel hydroxyl-derived compounds. Pharmacia, 73, Article e194529. https://doi.org/10.3897/pharmacia.73.e194529

Image Credits: AI Generated

DOI: 10.3897/pharmacia.73.e194529

Keywords: antioxidants, hydrazide-hydrazones, pyrrole, tryptophan, free radicals, DPPH assay, ABTS assay, molecular docking, Keap1-Nrf2, oxidative stress, structure-activity relationship, ADME